Characteristic | All participants | Past clinical research experience | ||||
---|---|---|---|---|---|---|
No/not sure, n | Yes, n | p value* | ||||
Total | 200 | 100% | 151 (76.6%) | 46 (23.4%) | ||
Mean age (years) | 58.3 ± 12.8 | |||||
Sex | Male | 90 | 45.90% | 65 (43.3%) | 24 (54.5%) | 0.189 |
Female | 106 | 54.10% | 85 (56.6%) | 20 (45.4%) | ||
Birthplace | Israel | 93 | 49.2% | 61 (41.5%) | 31 (68.9%) | 0.744 |
Russia† | 18 | 9.5% | 86 (58.5%) | 14 (31.1%) | ||
Europe | 56 | 29.6% | ||||
Africa | 11 | 5.80% | ||||
Asia | 5 | 2.6% | ||||
America | 6 | 3.1% | ||||
Education | Elementary/Junior high, | 15 | 7.60% | 94 (63.1%) | 15 (32.6%) | <0.0001 |
Professional school /agricultural | 23 | 11.70% | ||||
High school | 22 | 11.20% | ||||
Yeshiva (religious college) | 5 | 2.50% | ||||
Non-academic training | 46 | 23.40% | ||||
Academic | 86 | 43.70% | 55 (36.9%) | 31 (67.4%) | ||
Religion | Secular (non-religious Jewish) | 124 | 62.30% | 88 (58.3%) | 35 (76.1%) | 0.037 |
Observant | 50 | 25.10% | 63 (41.7%) | 11 (23.9%) | ||
Religious | 15 | 7.50% | ||||
Orthodox | 4 | 2.00% | ||||
Other | 6 | 3.00% | ||||
Residential Status | Alone | 35 | 17.60% | 22 (14.6%) | 13 (28.3%) | 0.046 |
With family/partner | 141 | 70.90% | 129 (85.4%) | 33 (71.7%) | ||
With caregiver | 10 | 5.00% | ||||
Other (nursing home, etc.) | 13 | 6.50% | ||||
Income | Much more than average | 8 | 4.10% | 36 (24.2%) | 19 (42.2%) | 0.194 |
More than average | 47 | 24.00% | ||||
Average | 45 | 23.00% | 80 (53.7%) | 17 (37.8%) | ||
Less than average | 31 | 15.80% | ||||
Much less than average | 23 | 11.70% | ||||
Perception of understanding how clinical trials work | Agree/strongly agree | 92 | 47.70% | 54 (36.5%) | 38 (84.4%) | <0.0001 |
Neutral/disagree/strongly disagree | 101 | 52.30% | 94 (63.5%) | 7 (15.6%) | ||
Agree to participate | Yes | 120 | 63.80% | 66 (44.9%) | 33 (73.3%) | 0.01 |
No | 67 | 35.60% | 81 (55.1%) | 12 (26.7%) | ||
Cancer site | Breast | 42 | 21.90% | |||
Colorectal | 33 | 17.20% | ||||
Lung | 20 | 10.40% | ||||
Prostate | 10 | 5.20% | ||||
Other | 87 | 45.30% |